NuCana (NCNA) Competitors $1.14 +0.03 (+2.70%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$1.13 -0.01 (-0.88%) As of 08:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NCNA vs. MBIO, PMCB, PHXM, EYEN, AWH, CDT, AYTU, TLPH, KPRX, and BCDAShould you be buying NuCana stock or one of its competitors? The main competitors of NuCana include Mustang Bio (MBIO), PharmaCyte Biotech (PMCB), PHAXIAM Therapeutics (PHXM), Eyenovia (EYEN), Aspira Women's Health (AWH), Conduit Pharmaceuticals (CDT), Aytu BioPharma (AYTU), Talphera (TLPH), Kiora Pharmaceuticals (KPRX), and BioCardia (BCDA). These companies are all part of the "pharmaceutical products" industry. NuCana vs. Mustang Bio PharmaCyte Biotech PHAXIAM Therapeutics Eyenovia Aspira Women's Health Conduit Pharmaceuticals Aytu BioPharma Talphera Kiora Pharmaceuticals BioCardia NuCana (NASDAQ:NCNA) and Mustang Bio (NASDAQ:MBIO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk. Does the MarketBeat Community prefer NCNA or MBIO? NuCana received 82 more outperform votes than Mustang Bio when rated by MarketBeat users. Likewise, 67.65% of users gave NuCana an outperform vote while only 64.26% of users gave Mustang Bio an outperform vote. CompanyUnderperformOutperformNuCanaOutperform Votes25167.65% Underperform Votes12032.35% Mustang BioOutperform Votes16964.26% Underperform Votes9435.74% Which has more volatility & risk, NCNA or MBIO? NuCana has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Mustang Bio has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500. Does the media prefer NCNA or MBIO? In the previous week, Mustang Bio had 8 more articles in the media than NuCana. MarketBeat recorded 8 mentions for Mustang Bio and 0 mentions for NuCana. Mustang Bio's average media sentiment score of -0.06 beat NuCana's score of -1.00 indicating that Mustang Bio is being referred to more favorably in the news media. Company Overall Sentiment NuCana Negative Mustang Bio Neutral Which has higher earnings and valuation, NCNA or MBIO? Mustang Bio is trading at a lower price-to-earnings ratio than NuCana, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuCanaN/AN/A-$34.37M-$10.48-0.11Mustang BioN/AN/A-$51.60M-$1.56-3.56 Do analysts rate NCNA or MBIO? NuCana currently has a consensus price target of $25.00, suggesting a potential upside of 2,092.98%. Mustang Bio has a consensus price target of $100.00, suggesting a potential upside of 1,701.80%. Given NuCana's higher probable upside, analysts plainly believe NuCana is more favorable than Mustang Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Mustang Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NCNA or MBIO more profitable? Mustang Bio's return on equity of 0.00% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets NuCanaN/A -314.47% -112.60% Mustang Bio N/A N/A -172.89% Do insiders & institutionals believe in NCNA or MBIO? 44.0% of NuCana shares are owned by institutional investors. Comparatively, 10.0% of Mustang Bio shares are owned by institutional investors. 31.2% of NuCana shares are owned by company insiders. Comparatively, 0.6% of Mustang Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryNuCana beats Mustang Bio on 8 of the 14 factors compared between the two stocks. Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCNA vs. The Competition Export to ExcelMetricNuCanaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.01M$6.22B$5.21B$9.14BDividend YieldN/A2.94%5.13%4.02%P/E Ratio-0.119.9189.4217.36Price / SalesN/A309.211,240.0477.11Price / CashN/A61.4443.7535.97Price / Book0.136.055.314.79Net Income-$34.37M$154.90M$122.54M$225.00M7 Day Performance9.62%1.35%1.42%2.37%1 Month Performance-5.79%0.41%2.51%4.40%1 Year Performance-84.79%3.08%25.29%20.10% NuCana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCNANuCana2.8551 of 5 stars$1.14+2.7%$25.00+2,093.0%-84.8%$3.01MN/A0.0030Negative NewsMBIOMustang Bio2.5778 of 5 stars$0.22-13.1%$2.00+797.3%-91.8%$10.65MN/A-0.14100Stock SplitPMCBPharmaCyte Biotech1.8652 of 5 stars$1.52+0.0%N/A-28.7%$10.59MN/A2.872Positive NewsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049EYENEyenovia2.4446 of 5 stars$0.09-12.5%$2.00+2,016.4%-95.9%$10.53M$31,832.00-0.1340Gap UpAWHAspira Women's Health3.628 of 5 stars$0.64+1.6%$4.40+586.4%-88.8%$10.43M$8.96M-0.52110Positive NewsGap DownCDTConduit PharmaceuticalsN/A$0.10-18.3%N/A-97.5%$10.36MN/A0.003Positive NewsGap DownAYTUAytu BioPharma0.9033 of 5 stars$1.69-2.9%N/A-31.4%$10.31M$79.76M-1.36160Positive NewsTLPHTalphera3.445 of 5 stars$0.61+0.8%$4.50+643.8%-23.9%$10.30M$281,000.00-0.8819KPRXKiora Pharmaceuticals3.2502 of 5 stars$3.35-4.8%$10.00+198.5%-20.6%$10.05M$16M0.0010Gap UpBCDABioCardia3.5353 of 5 stars$2.18+2.1%$25.00+1,049.4%-66.7%$9.97M$71,000.00-0.5240Positive NewsGap Down Related Companies and Tools Related Companies Mustang Bio Competitors PharmaCyte Biotech Competitors PHAXIAM Therapeutics Competitors Eyenovia Competitors Aspira Women's Health Competitors Conduit Pharmaceuticals Competitors Aytu BioPharma Competitors Talphera Competitors Kiora Pharmaceuticals Competitors BioCardia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NCNA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana plc Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCNA Stock Alerts